down arrow

SunLink Health Systems, Inc.

  • Market Cap: Micro Cap
  • Industry: Hospital
  • ISIN: US86737U1025
USD
1.11
0.00 (0.00%)

Aug 15

ASE

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

0.621.91
Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

How big is SunLink Health Systems, Inc.?

22-Jun-2025

As of Jun 18, SunLink Health Systems, Inc. has a market capitalization of 7.01 million, with net sales of 31.08 million and a net profit of -2.79 million for the latest four quarters ending in Mar'25. The company reported shareholder's funds of 15.97 million and total assets of 20.61 million as of Jun'24.

Market Cap: As of Jun 18, SunLink Health Systems, Inc. has a market capitalization of 7.01 million, categorizing it as a Micro Cap company.<BR><BR>Recent Quarterly Performance: For the latest four quarters ending in Mar'25, Dec'24, Sep'24, and Jun'24, SunLink Health Systems, Inc. reported net sales of 31.08 million and a net profit of -2.79 million.<BR><BR>Balance Sheet Snapshot: As of Jun'24, the company reported shareholder's funds of 15.97 million and total assets of 20.61 million.

Read More

What does SunLink Health Systems, Inc. do?

22-Jun-2025

SunLink Health Systems, Inc. operates in the healthcare sector, providing services through its subsidiaries in the hospital industry. As of March 2025, it reported net sales of $7 million and a net profit loss of $1 million, with a market cap of $7.01 million.

Overview:<BR>SunLink Health Systems, Inc. provides healthcare services through its subsidiaries in the hospital industry and operates within the micro-cap market.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: 7 Million (Quarterly Results - Mar 2025)<BR>Most recent Net Profit: -1 Million (Quarterly Results - Mar 2025)<BR>Market-cap: USD 7.01 Million (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: NA (Loss Making)<BR>Industry P/E: NA<BR>Dividend Yield: 0.00%<BR>Debt Equity: -0.54<BR>Return on Equity: -20.09%<BR>Price to Book: 0.52<BR><BR>Contact Details:<BR>Address: 900 Circle 75 Pkwy SE Ste 1120, ATLANTA GA: 30339-3005<BR>Tel: 1 770 9337000<BR>Website: http://www.sunlinkhealth.com/

Read More

Who are in the management team of SunLink Health Systems, Inc.?

22-Jun-2025

As of March 2022, the management team of SunLink Health Systems, Inc. includes Mr. Robert Thornton as Chairman, President, and CEO, along with independent directors Dr. Steven Baileys, Mr. Gene Burleson, Mr. C. Ford, Mr. Christopher Mills, and Mr. Howard Turner.

As of March 2022, the management team of SunLink Health Systems, Inc. includes Mr. Robert Thornton, who serves as the Chairman of the Board, President, and Chief Executive Officer. Additionally, the board features several independent directors: Dr. Steven Baileys, Mr. Gene Burleson, Mr. C. Ford, Mr. Christopher Mills, and Mr. Howard Turner.

Read More

Is SunLink Health Systems, Inc. overvalued or undervalued?

20-Sep-2025

As of September 28, 2022, SunLink Health Systems, Inc. is considered overvalued and risky due to poor financial metrics and long-term performance, despite a strong short-term stock return of 26.7%.

As of 28 September 2022, the valuation grade for SunLink Health Systems, Inc. moved from fair to risky, indicating a deterioration in its financial outlook. The company appears to be overvalued given its negative performance metrics, including a Price to Book Value of 0.46, an EV to EBIT of 0.28, and an EV to EBITDA of 0.50. In comparison to peers, Community Health Systems, Inc. has a P/E ratio of -2.9957 and an EV to EBITDA of 8.0222, while biote Corp. shows a P/E of 5.5497 and an EV to EBITDA of 6.2832, highlighting SunLink's relative weakness.<BR><BR>Despite the overvaluation, SunLink has shown strong short-term stock performance, with a year-to-date return of 26.7%, significantly outperforming the S&P 500's 12.22%. However, its long-term performance is concerning, with a 3-year return of -6.16% compared to the S&P 500's 70.41%, reinforcing the notion that the company may not be a sound investment at its current valuation.

Read More

Is SunLink Health Systems, Inc. technically bullish or bearish?

20-Sep-2025

As of August 14, 2025, SunLink Health Systems, Inc. shows a bullish technical trend supported by various indicators, although conflicting Dow Theory signals suggest caution despite strong recent performance compared to the S&P 500.

As of 14 August 2025, the technical trend for SunLink Health Systems, Inc. has changed from mildly bullish to bullish. The weekly and monthly MACD, Bollinger Bands, KST, and OBV all indicate a bullish stance, while the moving averages on the daily timeframe also support this bullish outlook. However, Dow Theory signals a bearish trend on both weekly and monthly timeframes, which introduces some caution. <BR><BR>In terms of performance, the stock has outperformed the S&P 500 over the past week (9.31% vs. 1.05%), month (11.5% vs. 2.33%), year-to-date (26.7% vs. 12.22%), and year (34.34% vs. 17.14%), but has underperformed over the 3-year (-6.16% vs. 70.41%) and 5-year (14.95% vs. 96.61%) periods. Overall, the current technical stance is bullish, but the conflicting Dow Theory signals suggest a need for caution.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Hospital

stock-summary
Market cap

USD 8 Million (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.54

stock-summary
Return on Equity

-20.09%

stock-summary
Price to Book

0.59

Revenue and Profits:
Net Sales:
7 Million
(Quarterly Results - Mar 2025)
Net Profit:
-1 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
29.65%
0%
29.65%
6 Months
15.9%
0%
15.9%
1 Year
34.34%
0%
34.34%
2 Years
18.47%
0%
18.47%
3 Years
-6.16%
0%
-6.16%
4 Years
-52.15%
0%
-52.15%
5 Years
14.95%
0%
14.95%

SunLink Health Systems, Inc. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News

Is SunLink Health Systems, Inc. technically bullish or bearish?

As of 14 August 2025, the technical trend for SunLink Health Systems, Inc. has changed from mildly bullish to bullish. The weekly and monthly MACD, Bollinger Bands, KST, and OBV all indicate a bullish stance, while the moving averages on the daily timeframe also support this bullish outlook. However, Dow Theory signals a bearish trend on both weekly and monthly timeframes, which introduces some caution. In terms of performance, the stock has outperformed the S&P 500 over the past week (9.31% vs. 1.05%), month (11.5% vs. 2.33%), year-to-date (26.7% vs. 12.22%), and year (34.34% vs. 17.14%), but has underperformed over the 3-year (-6.16% vs. 70.41%) and 5-year (14.95% vs. 96.61%) periods. Overall, the current technical stance is bullish, but the conflicting Dow Theory signals suggest a need for caution....

Read More

Is SunLink Health Systems, Inc. overvalued or undervalued?

As of 28 September 2022, the valuation grade for SunLink Health Systems, Inc. moved from fair to risky, indicating a deterioration in its financial outlook. The company appears to be overvalued given its negative performance metrics, including a Price to Book Value of 0.46, an EV to EBIT of 0.28, and an EV to EBITDA of 0.50. In comparison to peers, Community Health Systems, Inc. has a P/E ratio of -2.9957 and an EV to EBITDA of 8.0222, while biote Corp. shows a P/E of 5.5497 and an EV to EBITDA of 6.2832, highlighting SunLink's relative weakness. Despite the overvaluation, SunLink has shown strong short-term stock performance, with a year-to-date return of 26.7%, significantly outperforming the S&P 500's 12.22%. However, its long-term performance is concerning, with a 3-year return of -6.16% compared to the S&P 500's 70.41%, reinforcing the notion that the company may not be a sound investment at its curre...

Read More
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
-8.33%
EBIT Growth (5y)
-211.84%
EBIT to Interest (avg)
-2.29
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.54
Sales to Capital Employed (avg)
2.46
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
12.92%
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.46
EV to EBIT
0.28
EV to EBITDA
0.50
EV to Capital Employed
-0.16
EV to Sales
-0.03
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
-20.09%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Bearish
Bearish
OBV
Bullish
Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Mar 2025 is -7.59% vs 0.00% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Mar 2025 is 45.45% vs -175.00% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "7.30",
          "val2": "7.90",
          "chgp": "-7.59%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.40",
          "val2": "-0.70",
          "chgp": "42.86%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-0.10",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-0.60",
          "val2": "-1.10",
          "chgp": "45.45%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-93.30%",
          "val2": "-127.50%",
          "chgp": "3.42%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Jun'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Jun 2024 is -5.54% vs -16.95% in Jun 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Jun 2024 is -1,250.00% vs 111.76% in Jun 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'24",
        "Jun'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "32.40",
          "val2": "34.30",
          "chgp": "-5.54%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.80",
          "val2": "1.70",
          "chgp": "-147.06%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-2.30",
          "val2": "0.20",
          "chgp": "-1,250.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-74.30%",
          "val2": "2.20%",
          "chgp": "-7.65%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Mar'25 - QoQstock-summary
Mar'25
Dec'24
Change(%)
Net Sales
7.30
7.90
-7.59%
Operating Profit (PBDIT) excl Other Income
-0.40
-0.70
42.86%
Interest
0.00
0.00
Exceptional Items
0.00
-0.10
100.00%
Consolidate Net Profit
-0.60
-1.10
45.45%
Operating Profit Margin (Excl OI)
-93.30%
-127.50%
3.42%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

QoQ Growth in quarter ended Mar 2025 is -7.59% vs 0.00% in Dec 2024

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Mar 2025 is 45.45% vs -175.00% in Dec 2024

All Quarterly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Jun'24stock-summary
Jun'24
Jun'23
Change(%)
Net Sales
32.40
34.30
-5.54%
Operating Profit (PBDIT) excl Other Income
-0.80
1.70
-147.06%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
-2.30
0.20
-1,250.00%
Operating Profit Margin (Excl OI)
-74.30%
2.20%
-7.65%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Jun 2024 is -5.54% vs -16.95% in Jun 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Jun 2024 is -1,250.00% vs 111.76% in Jun 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About SunLink Health Systems, Inc. stock-summary
stock-summary
SunLink Health Systems, Inc.
Hospital
SunLink Health Systems, Inc., through its subsidiaries, owns businesses, which provide healthcare services in various markets in the United States. The Company's segments include Healthcare Facilities, Specialty Pharmacy, and Corporate and Other. Its Specialty Pharmacy segment is operated through its subsidiary, SunLink ScriptsRx, LLC (Scripts). As of June 30, 2016, its Healthcare Facilities segment subsidiaries owned and operated Trace Regional Hospital, which is a 84 bed community hospital and Floy Dyer Manor Nursing Home, which is a 66 bed nursing home in Mississippi, and Gilmer Nursing Home, which is a 100 bed nursing home in Georgia. As of June 30, 2016, the Specialty Pharmacy Segment subsidiary operated a specialty pharmacy business in Louisiana with four service lines. Its Specialty Pharmacy segment operates service lines, including retail pharmacy products and services; institutional pharmacy services; specialty pharmacy services, and durable medical equipment services.
Company Coordinates stock-summary
Company Details
900 Circle 75 Pkwy SE Ste 1120 , ATLANTA GA : 30339-3005
stock-summary
Tel: 1 770 9337000
stock-summary
http://www.sunlinkhealth.com/
stock-summary
Registrar Details
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."